Belite Bio宣布完成Dragon试验,这是一项为期两年的口服Tinlarebant治疗斯塔加特病的三期临床试验
Belite Bio宣布完成Dragon试验,这是一项为期两年的口服Tinlarebant治疗斯塔加特病的三期临床试验
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.